From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: The role of lymphocytes

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Madaro, Luca ^a   Bouché, Marina ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN; INTERLEUKIN 4; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CYTOTOXIC T LYMPHOCYTE; DYSFERLINOPATHY; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTE; MACROPHAGE; MAST CELL; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NEUTROPHIL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SKELETAL MUSCLE; T LYMPHOCYTE; ANIMAL; DUCHENNE MUSCULAR DYSTROPHY; IMMUNOLOGY; PATHOLOGY; REGENERATION; SKELETAL MUSCLE SATELLITE CELL;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MACROPHAGES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 84904214970     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/438675     Document Type: Review

References (102)

1. Saclier M., Cuvellier S., Magnan M., Mounier R., Chazaud B., Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS Journal 2013 280 17 4118 4130 2-s2.0-84882645143 10.1111/febs.12166
2. Mauro A., Satellite cell of skeletal muscle fibers. The Journal of Biophysical and Biochemical Cytology 1961 9 493 495 2-s2.0-0000642664
3. Seale P., Ishibashi J., Scimè A., Rudnicki M. A., Pax7 is necessary and sufficient for the myogenic specification of CD45+:Sca1+ stem cells from injured muscle. PLoS Biology 2004 2 5 E130 2-s2.0-19344373734 10.1371/journal.pbio.0020130 (Pubitemid 39234478)
4. Palacios D., Mozzetta C., Consalvi S., Caretti G., Saccone V., Proserpio V., Marquez V. E., Valente S., Mai A., Forcales S. V., Sartorelli V., Puri P. L., TNF/p38 /polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010 7 4 455 469 2-s2.0-77957357566 10.1016/j.stem.2010.08.013
5. Serrano A. L., Baeza-Raja B., Perdiguero E., Jardí M., Muñoz-Cánoves P., Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metabolism 2008 7 1 33 44 2-s2.0-37449022587 10.1016/j.cmet.2007.11.011
6. Kuang S., Gillespie M. A., Rudnicki M. A., Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008 2 1 22 31 2-s2.0-37548999686 10.1016/j.stem.2007.12.012
7. Ten Broek R. W., Grefte S., Von Den Hoff J. W., Regulatory factors and cell populations involved in skeletal muscle regeneration. Journal of Cellular Physiology 2010 224 1 7 16 2-s2.0-77952477337 10.1002/jcp.22127
8. Alexakis C., Partridge T., Bou-Gharios G., Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. The American Journal of Physiology-Cell Physiology 2007 293 2 C661 C669 2-s2.0-34547801173 10.1152/ajpcell.00061.2007 (Pubitemid 47235183)
9. Brack A. S., Conboy M. J., Roy S., Lee M., Kuo C. J., Keller C., Rando T. A., Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007 317 5839 807 810 2-s2.0-34547924424 10.1126/science.1144090 (Pubitemid 47257918)
10. Lapidos K. A., Kakkar R., McNally E. M., The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circulation Research 2004 94 8 1023 1031 2-s2.0-2342621479 10.1161/01.RES.0000126574.61061. 25 (Pubitemid 38579696)
11. Sacco A., Mourkioti F., Tran R., Choi J., Llewellyn M., Kraft P., Shkreli M., Delp S., Pomerantz J. H., Artandi S. E., Blau H. M., Short telomeres and stem cell exhaustion model duchenne muscular dystrophy in mdx/mTR mice. Cell 2010 143 7 1059 1071 2-s2.0-78650432352 10.1016/j.cell.2010.11.039
12. Bach J. R., Martinez D., Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respiratory Care 2011 56 6 744 750 2-s2.0-79960665553 10.4187/respcare.00831
13. Crisp A., Yin H., Goyenvalle A., Betts C., Moulton H. M., Seow Y., Babbs A., Merritt T., Saleh A. F., Gait M. J., Stuckey D. J., Clarke K., Davies K. E., Wood M. J. A., Diaphragm rescue alone prevents heart dysfunction in dystrophic mice in vitro. Human Molecular Genetics 2011 20 3 413 421 2-s2.0-78651068846 10.1093/hmg/ddq477
14. Mosqueira M., Baby S. M., Lahiri S., Khurana T. S., Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD). PLoS ONE 2013 8 7 2-s2.0-84880814550 10.1371/journal.pone. 0069567 e69567
15. Mourkioti F., Kustan J., Kraft P., Day J. W., Zhao M.-M., Kost-Alimova M., Protopopov A., Depinho R. A., Bernstein D., Meeker A. K., Blau H. M., Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. Nature Cell Biology 2013 15 8 895 904 2-s2.0-84881475183 10.1038/ncb2790
16. Evans N. P., Misyak S. A., Robertson J. L., Bassaganya-Riera J., Grange R. W., Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in duchenne muscular dystrophy. The American Journal of Physical Medicine and Rehabilitation 2009 88 6 502 522 2-s2.0-66949154340 10.1097/PHM.0b013e3181a5a24f
17. Heredia J. E., Mukundan L., Chen F. M., Mueller A. A., Deo R. C., Locksley R. M., Rando T. A., Chawla A., Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013 153 2 376 388 2-s2.0-84876274371 10.1016/j.cell.2013.02.053
18. Arnold L., Henry A., Poron F., Baba-Amer Y., Van Rooijen N., Plonquet A., Gherardi R. K., Chazaud B., Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. Journal of Experimental Medicine 2007 204 5 1057 1069 2-s2.0-34248997759 10.1084/jem.20070075 (Pubitemid 46798150)
19. Deng B., Wehling-Henricks M., Villalta S. A., Wang Y., Tidball J. G., IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. Journal of Immunology 2012 189 7 3669 3680 2-s2.0-84866551217 10.4049/jimmunol.1103180
20. Zhang C., Li Y., Wu Y., Wang L., Wang X., Du J., Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. Journal of Biological Chemistry 2013 288 3 1489 1499 2-s2.0-84872742337 10.1074/jbc.M112.419788
21. Kharraz Y., Guerra J., Mann C. J., Serrano A. L., Muñoz- Cánoves P., Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators of Inflammation 2013 2013 9 2-s2.0-84874534408 10.1155/2013/491497 491497
22. Tidball J. G., Villalta S. A., Regulatory interactions between muscle and the immune system during muscle regeneration. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2010 298 5 R1173 R1187 2-s2.0-77951700255 10.1152/ajpregu.00735.2009
23. Shireman P. K., Contreras-Shannon V., Ochoa O., Karia B. P., Michalek J. E., McManus L. M., MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. Journal of Leukocyte Biology 2007 81 3 775 785 2-s2.0-33847772967 10.1189/jlb.0506356 (Pubitemid 46393555)
24. Nguyen H. X., Lusis A. J., Tidball J. G., Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo. Journal of Physiology 2005 565 2 403 413 2-s2.0-21044449794 10.1113/jphysiol.2005.085506 (Pubitemid 40872471)
25. Hodgetts S., Radley H., Davies M., Grounds M. D., Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNF function with Etanercept in mdx mice. Neuromuscular Disorders 2006 16 9-10 591 602 2-s2.0-33748519220 10.1016/j.nmd.2006.06.011 (Pubitemid 44374323)
26. Nguyen H. X., Tidball J. G., Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice. Journal of Physiology 2003 553 3 833 841 2-s2.0-0347659044 10.1113/jphysiol.2003.051912 (Pubitemid 38035625)
27. Daley J. M., Thomay A. A., Connolly M. D., Reichner J. S., Albina J. E., Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. Journal of Leukocyte Biology 2008 83 1 64 70 2-s2.0-38149005534 10.1189/jlb.0407247
28. Fleming T. J., Fleming M. L., Malek T. R., Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow: RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. Journal of Immunology 1993 151 5 2399 2408 2-s2.0-0027272534 (Pubitemid 23264492)
29. Pillon N. J., Bilan P. J., Fink L. N., Klip A., Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. The American Journal of Physiology-Endocrinology and Metabolism 2013 304 5 E453 E465 2-s2.0-84874543773 10.1152/ajpendo.00553.2012
30. Côté C. H., Bouchard P., van Rooijen N., Marsolais D., Duchesne E., Monocyte depletion increases local proliferation of macrophage subsets after skeletal muscle injury. BMC Musculoskeletal Disorders 2013 14, article 359 10.1186/1471-2474-14-359
31. Perdiguero E., Sousa-Victor P., Ruiz-Bonilla V., Jardí M., Caelles C., Serrano A. L., Muñoz-Cánoves P., p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. Journal of Cell Biology 2011 195 2 307 322 2-s2.0-80155206776 10.1083/jcb.201104053
32. Wynn T. A., Chawla A., Pollard J. W., Macrophage biology in development, homeostasis and disease. Nature 2013 496 7446 445 455 2-s2.0-84876800337 10.1038/nature12034
33. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
34. Mounier R., Théret M., Arnold L., Cuvellier S., Bultot L., Göransson O., Sanz N., Ferry A., Sakamoto K., Foretz M., Viollet B., Chazaud B., AMPK 1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metabolism 2013 18 2 251 264 2-s2.0-84881356321 10.1016/j.cmet.2013.06.017
35. Villalta S. A., Nguyen H. X., Deng B., Gotoh T., Tidbal J. G., Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Human Molecular Genetics 2009 18 3 482 496 2-s2.0-58749098598 10.1093/hmg/ddn376
36. Vidal B., Ardite E., Suelves M., Ruiz-Bonilla V., Janué A., Flick M. J., Degen J. L., Serrano A. L., Muñoz-Cánoves P., Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the m β 2 leukocyte integrin receptor. Human Molecular Genetics 2012 21 9 1989 2004 2-s2.0-84859308196 10.1093/hmg/dds012
37. Wehling M., Spencer M. J., Tidball J. G., A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. Journal of Cell Biology 2001 155 1 123 131 2-s2.0-0035494438 10.1083/jcb.200105110 (Pubitemid 34286213)
38. Summan M., Warren G. L., Mercer R. R., Chapman R., Hulderman T., Van Rooijen N., Simeonova P. P., Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2006 290 6 R1488 R1495 2-s2.0-33744821877 10.1152/ajpregu.00465.2005 (Pubitemid 43830809)
39. Teixeira C. F. P., Zamunér S. R., Zuliani J. P., Fernandes C. M., Cruz-Hofling M. A., Fernandes I., Chaves F., Gutiérrez J. M., Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle and Nerve 2003 28 4 449 459 2-s2.0-0141592399 10.1002/mus.10453 (Pubitemid 37193773)
40. Gorospe J. R. M., Nishikawa B. K., Hoffman E. P., Recruitment of mast cells to muscle after mild damage. Journal of the Neurological Sciences 1996 135 1 10 17 2-s2.0-0030028683 10.1016/0022-510X(95)00255-Z (Pubitemid 26019016)
41. Abonia J. P., Friend D. S., Austen W. G. Jr., Moore F. D. Jr., Carroll M. C., Chan R., Afnan J., Humbles A., Gerard C., Knight P., Kanaoka Y., Yasuda S., Morokawa N., Austen K. F., Stevens R. L., Gurish M. F., Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. Journal of Immunology 2005 174 11 7285 7291 2-s2.0-21044433149 (Pubitemid 40705698)
42. Radley H. G., Grounds M. D., Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiology of Disease 2006 23 2 387 397 2-s2.0-33746239685 10.1016/j.nbd.2006.03.016 (Pubitemid 44097034)
43. Binstadt B. A., Patel P. R., Alencar H., Nigrovic P. A., Lee D. M., Mahmood U., Weissleder R., Mathis D., Benoist C., Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nature Immunology 2006 7 3 284 292 2-s2.0-33645940600 10.1038/ni1306
44. Yokota M., Suzuki K., Tokoyoda K., Meguro K., Hosokawa J., Tanaka S., Ikeda K., Mikata T., Nakayama T., Kohsaka H., Nakajima H., Roles of mast cells in the pathogenesis of inflammatory myopathy. Arthritis Research & Therapy 2014 16 2 R72 10.1186/ar4512
45. Dimachkie M. M., Idiopathic inflammatory myopathies. Journal of Neuroimmunology 2011 231 1-2 32 42 2-s2.0-79952443273 10.1016/j.jneuroim.2010. 10.013
46. Casciola-Rosen L., Nagaraju K., Plotz P., Wang K., Levine S., Gabrielson E., Corse A., Rosen A., Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. Journal of Experimental Medicine 2005 201 4 591 601 2-s2.0-14244267901 10.1084/jem.20041367 (Pubitemid 40289549)
47. Silberstein D. S., David J. R., Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proceedings of the National Academy of Sciences of the United States of America 1986 83 4 1055 1059 2-s2.0-0022450403 (Pubitemid 16086410)
48. Ben Baruch-Morgenstern N., Shik D., Moshkovits I., Itan M., Karo-Atar D., Bouffi C., Fulkerson P. C., Rashkovan D., Jung S., Rothenberg M. E., Munitz A., Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development. Nature Immunology 2014 15 1 36 44
49. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K., Suda T., Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. Journal of Experimental Medicine 1988 167 5 1737 1742 2-s2.0-0023893708
50. Wehling-henricks M., Sokolow S., Lee J. J., Myung K. H., Villalta S. A., Tidball J. G., Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Human Molecular Genetics 2008 17 15 2280 2292 2-s2.0-48049084529 10.1093/hmg/ddn129
51. Cai B., Spencer M. J., Nakamura G., Tseng-Ong L., Tidball J. G., Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. The American Journal of Pathology 2000 156 5 1789 1796 2-s2.0-0033838714 (Pubitemid 30646716)
52. Wehling-Henricks M., Lee J. J., Tidball J. G., Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle. Neuromuscular Disorders 2004 14 8-9 483 490 2-s2.0-4344632582 10.1016/j.nmd.2004.04.008 (Pubitemid 39141703)
53. Horsley V., Jansen K. M., Mills S. T., Pavlath G. K., IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 2003 113 4 483 494 2-s2.0-0037726553 10.1016/S0092-8674(03)00319-2 (Pubitemid 36588751)
54. Uezumi A., Fukada S.-I., Yamamoto N., Takeda S., Tsuchida K., Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nature Cell Biology 2010 12 2 143 152 2-s2.0-75949130333 10.1038/ncb2014
55. Joe A. W. B., Yi L., Natarajan A., Le Grand F., So L., Wang J., Rudnicki M. A., Rossi F. M. V., Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nature Cell Biology 2010 12 2 153 163 2-s2.0-75949096894 10.1038/ncb2015
56. Mozzetta C., Consalvi S., Saccone V., Tierney M., Diamantini A., Mitchell K. J., Marazzi G., Borsellino G., Battistini L., Sassoon D., Sacco A., Puri P. L., Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Molecular Medicine 2013 5 4 626 639 2-s2.0-84875805687 10.1002/emmm.201202096
57. Cordani N., Pisa V., Pozzi L., Sciorati C., Clementi E., Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 2014 32 4 874 885 10.1002/stem.1587
58. Choi J.-H., Park Y.-E., Kim S.-I., Kim J.-I., Lee C.-H., Park K.-H., Kim D.-S., Differential Immunohistological features of inflammatory myopathies and dysferlinopathy. Journal of Korean Medical Science 2009 24 6 1015 1023 2-s2.0-75349083088 10.3346/jkms.2009.24.6.1015
59. Marino M., Scuderi F., Mazzarelli P., Mannella F., Provenzano C., Bartoccioni E., Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts. Journal of Neuroimmunology 2001 116 1 94 101 2-s2.0-0035341223 10.1016/S0165-5728(01)00287- 9 (Pubitemid 32322643)
60. Schmidt J., Rakocevic G., Raju R., Dalakas M. C., Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain 2004 127 5 1182 1190 2-s2.0-2442481908 10.1093/brain/awh148 (Pubitemid 38623051)
61. Lerario A., Cogiamanian F., Marchesi C., Belicchi M., Bresolin N., Porretti L., Torrente Y., Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy. BMC Musculoskeletal Disorders 2010 11, article 157 2-s2.0-77954320707 10.1186/1471-2474-11-157
62. Salajegheh M., Pinkus J. L., Amato A. A., Morehouse C., Jallal B., Yao Y., Greenberg S. A., Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle and Nerve 2010 42 4 576 583 2-s2.0-77957684922 10.1002/mus.21739
63. +) T cells promote the pathology of dystrophin-deficient muscle. Clinical Immunology 2001 98 2 235 243 2-s2.0-0035122405 10.1006/clim.2000.4966 (Pubitemid 32150612)
64. Eghtesad S., Jhunjhunwala S., Little S. R., Clemens P. R., Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle. Molecular Medicine 2011 17 9-10 917 924 2-s2.0-84858780524
65. Tsoukas C. D., Landgraf B., Bentin J., Valentine M., Lotz M., Vaughan J. H., Carson D. A., Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes. Journal of Immunology 1985 135 3 1719 1723 2-s2.0-0022357820 (Pubitemid 16245354)
66. Al-Shanti N., Durcan P., Al-Dabbagh S., Dimchev G. A., Stewart C. E., Activated lymphocytes secretome inhibits differentiation and induces proliferation of C2C12 myoblasts. Cellular Physiology and Biochemistry 2014 33 1 117 128 10.1159/000356655
67. Kissel J. T., Lynn D. J., Rammohan K. W., Klein J. P., Griggs R. C., Moxley R. T. III, Cwik V. A., Brooke M. H., Mendell J. R., Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy. Neurology 1993 43 3 532 536 2-s2.0-0027409960 (Pubitemid 23088487)
68. Mendell J. R., Moxley R. T., Griggs R. C., Brooke M. H., Fenichel G. M., Miller J. P., King W., Signore L., Pandya S., Florence J., Schierbecker J., Robison J., Kaiser K., Mandel S., Arfken C., Gilder B., Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. The New England Journal of Medicine 1989 320 24 1592 1597 2-s2.0-0024332294 (Pubitemid 19154573)
69. Gussoni E., Pavlath G. K., Miller R. G., Panzara M. A., Powell M., Blau H. M., Steinman L., Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. Journal of Immunology 1994 153 10 4798 4805 2-s2.0-0028075601 (Pubitemid 24346875)
70. Mantegazza R., Andreetta F., Bernasconi P., Baggi F., Oksenberg J. R., Simoncini O., Mora M., Cornelio F., Steinman L., Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V / β rearrangements may indicate antigen-driven selection. Journal of Clinical Investigation 1993 91 6 2880 2886 2-s2.0-0027272073 (Pubitemid 23182549)
71. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 10.1038/nri978 (Pubitemid 37328697)
72. Burzyn D., Kuswanto W., Kolodin D., Shadrach J. L., Cerletti M., Jang Y., Sefik E., Tan T. G., Wagers A. J., Benoist C., Mathis D., A special population of regulatory T cells potentiates muscle repair. Cell 2013 155 6 1282 1295 10.1016/j.cell.2013.10.054
73. Wang P., Zheng S. G., Regulatory T cells and B cells: implication on autoimmune diseases. International Journal of Clinical and Experimental Pathology 2013 6 12 2668 2674
74. Farini A., Meregalli M., Belicchi M., Battistelli M., Parolini D., D'Antona G., Gavina M., Ottoboni L., Constantin G., Bottinelli R., Torrente Y., T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. Journal of Pathology 2007 213 2 229 238 2-s2.0-35349000178 10.1002/path.2213 (Pubitemid 47612245)
75. Morrison J., Palmer D. B., Cobbold S., Partridge T., Bou-Gharios G., Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse. The American Journal of Pathology 2005 166 6 1701 1710 2-s2.0-19544374647 (Pubitemid 40734393)
76. - mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies. Molecular Therapy 2013 21 10 1950 1957 10.1038/mt.2013.186
77. Vetrone S. A., Montecino-Rodriguez E., Kudryashova E., Kramerova I., Hoffman E. P., Liu S. D., Miceli M. C., Spencer M. J., Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF- β Journal of Clinical Investigation 2009 119 6 1583 1594 2-s2.0-67651005390 10.1172/JCI37662
78. Madaro L., Pelle A., Nicoletti C., Crupi A., Marrocco V., Bossi G., Soddu S., Bouché M., PKC theta ablation improves healing in a mouse model of muscular dystrophy. PLoS ONE 2012 7 2 2-s2.0-84856850591 10.1371/journal.pone. 0031515 e31515
79. Gao Z., Wang Z., Zhang X., Butler A. A., Zuberi A., Gawronska-Kozak B., Lefevre M., York D., Ravussin E., Berthoud H.-R., McGuinness O., Cefalu W. T., Ye J., Inactivation of PKC θ leads to increased susceptibility to obesity and dietary insulin resistance in mice. The American Journal of Physiology-Endocrinology and Metabolism 2007 292 1 E84 E91 2-s2.0-33845989841 10.1152/ajpendo.00178.2006 (Pubitemid 46052929)
80. Madaro L., Marrocco V., Fiore P., Aulino P., Smeriglio P., Adamo S., Molinaro M., Bouché M., PKC θ signaling is required for myoblast fusion by regulating the expression of caveolin-3 and β 1D integrin upstream focal adhesion kinase. Molecular Biology of the Cell 2011 22 8 1409 1419 2-s2.0-79954602263 10.1091/mbc.E10-10-0821
81. Messina G., Biressi S., Monteverde S., Magli A., Cassano M., Perani L., Roncaglia E., Tagliafico E., Starnes L., Campbell C. E., Grossi M., Goldhamer D. J., Gronostajski R. M., Cossu G., Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell 2010 140 4 554 566 2-s2.0-77049114286 10.1016/j.cell.2010.01.027
82. D'Andrea M., Pisaniello A., Serra C., Senni M. I., Castaldi L., Molinaro M., Bouché M., Protein kinase C theta co-operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells. Journal of Cellular Physiology 2006 207 2 379 388 2-s2.0-33645655559 10.1002/jcp.20585
83. Madaro L., Marrocco V., Carnio S., Sandri M., Bouché M., Intracellular signaling in ER stress-induced autophagy in skeletal muscle cells. The FASEB Journal 2013 27 5 1990 2000 2-s2.0-84877101291 10.1096/fj.12-215475
84. Valenzuela J. O., Iclozan C., Hossain M. S., Prlic M., Hopewell E., Bronk C. C., Wang J., Celis E., Engelman R. W., Blazar B. R., Bevan M. J., Waller E. K., Yu X.-Z., Beg A. A., PKC θ is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. Journal of Clinical Investigation 2009 119 12 3774 3786 2-s2.0-72849123229 10.1172/JCI39692
85. Gruber T., Hermann-Kleiter N., Pfeifhofer-Obermair C., Lutz-Nicoladoni C., Thuille N., Letschka T., Barsig J., Baudler M., Li J., Metzler B., Nüsslein-Hildesheim B., Wagner J., Leitges M., Baier G., PKC θ cooperates with PKC in alloimmune responses of T cells in vivo. Molecular Immunology 2009 46 10 2071 2079 2-s2.0-67349256328 10.1016/j.molimm.2009.02.030
86. Marsland B. J., Soos T. J., Späth G., Littman D. R., Kopf M., Protein kinase C θ is critical for the development of in vivo T helper (Th)2 cell but not Th-1 cell responses. Journal of Experimental Medicine 2004 200 2 181 189 2-s2.0-3242790172 10.1084/jem.20032229 (Pubitemid 38982177)
87. Healy A. M., Izmailova E., Fitzgerald M., Walker R., Hattersley M., Silva M., Siebert E., Terkelsen J., Picarella D., Pickard M. D., LeClair B., Chandra S., Jaffee B., PKC- θ -deficient mice are protected from th1-dependent antigen-induced arthritis. Journal of Immunology 2006 177 3 1886 1893 2-s2.0-33746210212 (Pubitemid 44092528)
88. Tan S.-L., Zhao J., Bi C., Chen X. C., Hepburn D. L., Wang J., Sedgwick J. D., Chintalacharuvu S. R., Na S., Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C θ -deficient mice. Journal of Immunology 2006 176 5 2872 2879 2-s2.0-33644512418
89. Nagahama K., Ogawa A., Shirane K., Shimomura Y., Sugimoto K., Mizoguchi A., Protein kinase C theta plays a fundamental role in different types of chronic colitis. Gastroenterology 2008 134 2 459 469 2-s2.0-38649118188 10.1053/j.gastro.2007.11.005 (Pubitemid 351173043)
90. Zanin-Zhorov A., Ding Y., Kumari S., Attur M., Hippen K. L., Brown M., Blazar B. R., Abramson S. B., Lafaille J. J., Dustin M. L., Protein kinase C- θ mediates negative feedback on regulatory T cell function. Science 2010 328 5976 372 376 2-s2.0-77951158406 10.1126/science.1186068
91. Ma J., Ding Y., Fang X., Wang R., Sun Z., Protein kinase C- θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a- dependent pathway. Journal of Immunology 2012 188 11 5337 5347 2-s2.0-84862072065 10.4049/jimmunol.1102979
92. Farini A., Sitzia C., Navarro C., D'Antona G., Belicchi M., Parolini D., Del Fraro G., Razini P., Bottinelli R., Meregalli M., Torrente Y., Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model. Experimental Cell Research 2012 318 10 1160 1174 2-s2.0-84860368512 10.1016/j.yexcr.2012.03.010
93. Han R., Campbell K. P., Dysferlin and muscle membrane repair. Current Opinion in Cell Biology 2007 19 4 409 416 2-s2.0-34548009359 10.1016/j.ceb.2007.07.001 (Pubitemid 47277508)
94. Liao H., Franck E., Fréret M., Adriouch S., Baba-Amer Y., Authier F.-J., Boyer O., Gherardi R. K., Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model. Arthritis and Rheumatism 2012 64 10 3441 3451 2-s2.0-84869073601 10.1002/art.34551
95. Young N. A., Sharma R., Friedman A. K., Kaffenberger B. H., Bolon B., Jarjour W. N., Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu. Arthritis & Rheumatism 2013 65 12 3259 3270 10.1002/art.38184
96. Chakrabarti S., Kobayashi K. S., Flavell R. A., Marks C. B., Miyake K., Liston D. R., Fowler K. T., Gorelick F. S., Andrews N. W., Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. Journal of Cell Biology 2003 162 4 543 549 2-s2.0-0042978564 10.1083/jcb.200305131 (Pubitemid 37022933)
97. Josefowicz S. Z., Regulators of chromatin state and transcription in CD4 T-cell polarization. Immunology 2013 139 3 299 308 2-s2.0-84879235768 10.1111/imm.12115
98. Golding J. P., Calderbank E., Partridge T. A., Beauchamp J. R., Skeletal muscle stem cells express anti-apoptotic ErbB receptors during activation from quiescence. Experimental Cell Research 2007 313 2 341 356 2-s2.0-33846059442 10.1016/j.yexcr.2006.10.019 (Pubitemid 46055263)
99. Andrechek E. R., Hardy W. R., Girgis-Gabardo A. A., Perry R. L. S., Butler R., Graham F. L., Kahn R. C., Rudnicki M. A., Muller W. J., ErbB2 is required for muscle spindle and myoblast cell survival. Molecular and Cellular Biology 2002 22 13 4714 4722 2-s2.0-0036269883 10.1128/MCB.22.13.4714-4722.2002 (Pubitemid 34620407)
100. Wiendl H., Hohlfeld R., Kieseier B. C., Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends in Immunology 2005 26 7 373 380 2-s2.0-20644433088 10.1016/j.it.2005.05.003 (Pubitemid 40835843)
101. Srinivasan M., Frauwirth K. A., Peripheral tolerance in CD8+ T cells. Cytokine 2009 46 2 147 159 2-s2.0-65049084052 10.1016/j.cyto.2009.01.010
102. Spencer M. J., Walsh C. M., Dorshkind K. A., Rodriguez E. M., Tidball J. G., Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. Journal of Clinical Investigation 1997 99 11 2745 2751 2-s2.0-0031010857 (Pubitemid 27259822)